4//SEC Filing
Niklason Laura E 4
Accession 0001818382-24-000214
CIK 0001818382other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 7:31 AM ET
Size
7.7 KB
Accession
0001818382-24-000214
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Niklason Laura E
DirectorPresident, CEO and Director
Transactions
- Purchase
Common Stock
2024-11-19$4.44/sh+1,797$7,979→ 243,851 total
Holdings
- 510,161(indirect: By Spouse)
Common Stock
- 1,148,240(indirect: By Trust)
Common Stock
- 1,730,884(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]This purchase is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person's spouse, of 809,786 shares of the Issuer's common stock on May 31, 2024. The Reporting Person has paid the Issuer $8,778.23, representing the full amount of profit realized in connection with this purchase.
- [F2]The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $4.435 to $4.4352. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001878075
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 7:31 AM ET
- Size
- 7.7 KB